Custirsen
Custirsen is an experimental antisense oligonucleotide designed for the treatment of cancer. It specifically targets and binds to the mRNA of the clusterin gene, leading to a decrease in clusterin protein production. Clusterin is a chaperone protein that is implicated in cancer cell survival, resistance to chemotherapy, and apoptosis (programmed cell death). By inhibiting clusterin, custirsen aims to enhance the effectiveness of chemotherapy and radiation therapy in cancer patients.
Mechanism of Action[edit | edit source]
Custirsen works by utilizing antisense technology, a form of genetic intervention that prevents genes from producing their respective proteins. It is designed to bind specifically to the mRNA of the clusterin gene. Once bound, it triggers the destruction of the mRNA, thereby preventing the translation and production of the clusterin protein. This reduction in clusterin levels is thought to sensitize cancer cells to conventional cancer treatments, such as chemotherapy and radiation therapy, by diminishing the cells' ability to resist programmed cell death.
Clinical Trials[edit | edit source]
Custirsen has been evaluated in several clinical trials for its effectiveness and safety in treating various types of cancer, including prostate cancer, lung cancer, and others. These studies have explored custirsen as both a monotherapy and in combination with other cancer treatments. The outcomes of these trials have been mixed, with some showing promise in extending survival or improving response rates, while others have not met their primary endpoints.
Potential Applications[edit | edit source]
The primary application of custirsen is in the treatment of cancers where clusterin is known to play a role in disease progression and treatment resistance. By targeting a specific mechanism of resistance, custirsen could potentially improve the efficacy of existing cancer therapies, offering hope for better outcomes in patients with difficult-to-treat cancers.
Challenges and Future Directions[edit | edit source]
Despite the potential benefits, the development of custirsen has faced challenges. The variability in clinical trial results has led to questions about its efficacy across different cancer types and patient populations. Future research may focus on identifying specific biomarkers that predict response to custirsen, optimizing dosing strategies, and exploring combination therapies that could enhance its therapeutic potential.
Transform your life with W8MD's budget GLP1 injections from $125 and up biweekly
W8MD offers a medical weight loss program NYC and a clinic to lose weight in Philadelphia. Our W8MD's physician supervised medical weight loss centers in NYC provides expert medical guidance, and offers telemedicine options for convenience.
Why choose W8MD?
- Comprehensive care with FDA-approved weight loss medications including:
- loss injections in NYC both generic and brand names:
- weight loss medications including Phentermine, Qsymia, Contrave, Diethylpropion etc.
- Accept most insurances for visits or discounted self pay cost.
- Generic weight loss injections starting from just $125.00 for the starting dose
- In person weight loss NYC and telemedicine medical weight loss options in New York city available
Book Your Appointment
Start your NYC weight loss journey today at our NYC medical weight loss, and Philadelphia and visit Philadelphia medical weight loss Call (718)946-5500 for NY and 215 676 2334 for PA
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's NYC physician weight loss.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available. Call 718 946 5500.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD